Compare Piramal Healthcare with Procter & Gamble Health - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PIRAMAL ENTERPRISES vs PROCTER & GAMBLE HEALTH - Comparison Results

PIRAMAL ENTERPRISES     Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

PROCTER & GAMBLE HEALTH 
   Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PIRAMAL ENTERPRISES PROCTER & GAMBLE HEALTH PIRAMAL ENTERPRISES/
PROCTER & GAMBLE HEALTH
 
P/E (TTM) x 12.0 43.7 27.6% View Chart
P/BV x 0.8 4.5 18.4% View Chart
Dividend Yield % 2.1 10.5 20.3%  

Financials

 PIRAMAL ENTERPRISES   PROCTER & GAMBLE HEALTH
EQUITY SHARE DATA
    PIRAMAL ENTERPRISES
Mar-19
PROCTER & GAMBLE HEALTH
Dec-18
PIRAMAL ENTERPRISES/
PROCTER & GAMBLE HEALTH
5-Yr Chart
Click to enlarge
High Rs3,3033,549 93.1%   
Low Rs1,7971,301 138.1%   
Sales per share (Unadj.) Rs716.5511.4 140.1%  
Earnings per share (Unadj.) Rs79.761.3 130.0%  
Cash flow per share (Unadj.) Rs107.974.0 145.8%  
Dividends per share (Unadj.) Rs28.00440.00 6.4%  
Dividend yield (eoy) %1.118.1 6.1%  
Book value per share (Unadj.) Rs1,477.5927.8 159.3%  
Shares outstanding (eoy) m184.4516.60 1,111.1%   
Bonus/Rights/Conversions IS--  
Price / Sales ratio x3.64.7 75.0%   
Avg P/E ratio x32.039.6 80.8%  
P/CF ratio (eoy) x23.632.8 72.1%  
Price / Book Value ratio x1.72.6 66.0%  
Dividend payout %35.1717.9 4.9%   
Avg Mkt Cap Rs m470,29240,257 1,168.2%   
No. of employees `0007.81.1 689.6%   
Total wages/salary Rs m22,5041,313 1,714.3%   
Avg. sales/employee Rs Th16,899.47,486.7 225.7%   
Avg. wages/employee Rs Th2,877.71,157.6 248.6%   
Avg. net profit/employee Rs Th1,879.9897.2 209.5%   
INCOME DATA
Net Sales Rs m132,1538,490 1,556.6%  
Other income Rs m3,128244 1,282.5%   
Total revenues Rs m135,2818,734 1,548.9%   
Gross profit Rs m66,2901,482 4,474.2%  
Depreciation Rs m5,202211 2,462.8%   
Interest Rs m44,0970-   
Profit before tax Rs m20,1191,514 1,328.6%   
Minority Interest Rs m3,1940-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m066 0.0%   
Tax Rs m8,611563 1,530.9%   
Profit after tax Rs m14,7011,017 1,445.0%  
Gross profit margin %50.217.5 287.4%  
Effective tax rate %42.837.1 115.2%   
Net profit margin %11.112.0 92.8%  
BALANCE SHEET DATA
Current assets Rs m122,74215,343 800.0%   
Current liabilities Rs m310,8101,960 15,856.0%   
Net working cap to sales %-142.3157.6 -90.3%  
Current ratio x0.47.8 5.0%  
Inventory Days Days2349 47.3%  
Debtors Days Days3928 136.5%  
Net fixed assets Rs m116,9041,209 9,667.1%   
Share capital Rs m369166 222.2%   
"Free" reserves Rs m272,16115,235 1,786.4%   
Net worth Rs m272,53015,401 1,769.6%   
Long term debt Rs m270,1960-   
Total assets Rs m856,26117,595 4,866.6%  
Interest coverage x1.5NM-  
Debt to equity ratio x1.00-  
Sales to assets ratio x0.20.5 32.0%   
Return on assets %6.95.8 118.8%  
Return on equity %5.46.6 81.7%  
Return on capital %12.410.3 121.1%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m15,2001,636 928.9%   
Fx outflow Rs m4,8894,368 111.9%   
Net fx Rs m10,312-2,732 -377.5%   
CASH FLOW
From Operations Rs m-115,975-1,304 8,895.1%  
From Investments Rs m-8,26512,697 -65.1%  
From Financial Activity Rs m107,525-301 -35,782.0%  
Net Cashflow Rs m-16,65011,093 -150.1%  

Share Holding

Indian Promoters % 52.9 0.0 -  
Foreign collaborators % 0.0 51.8 -  
Indian inst/Mut Fund % 4.0 18.2 22.0%  
FIIs % 26.6 1.0 2,660.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 16.5 29.1 56.7%  
Shareholders   93,274 28,591 326.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PIRAMAL ENTERPRISES With:   GLENMARK PHARMA  FULFORD INDIA  DR. REDDYS LAB  AJANTA PHARMA  UNICHEM LAB  

Compare PIRAMAL ENTERPRISES With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

How to Trade this Market Crash(Podcast)

India's #1 trader, Vijay Bhambwani, decodes the crash...and reveals hidden opportunities one could profit from.

Related Views on News

PIRAMAL ENTERPRISES Announces Quarterly Results (3QFY20); Net Profit Up 11.7% (Quarterly Result Update)

Feb 5, 2020 | Updated on Feb 5, 2020

For the quarter ended December 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 6 bn (up 11.7% YoY). Sales on the other hand came in at Rs 38 bn (up 9.1% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

PROCTER & GAMBLE HEALTH Announces Quarterly Results (2QFY20); Net Profit Down 13.0% (Quarterly Result Update)

Nov 14, 2019 | Updated on Nov 14, 2019

For the quarter ended September 2019, PROCTER & GAMBLE HEALTH has posted a net profit of Rs 358 m (down 13.0% YoY). Sales on the other hand came in at Rs 2 bn (down 0.4% YoY). Read on for a complete analysis of PROCTER & GAMBLE HEALTH's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (2QFY20); Net Profit Up 16.5% (Quarterly Result Update)

Oct 25, 2019 | Updated on Oct 25, 2019

For the quarter ended September 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 6 bn (up 16.5% YoY). Sales on the other hand came in at Rs 36 bn (up 14.6% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

PROCTER & GAMBLE HEALTH Announces Quarterly Results (1QFY20); Net Profit Up 34.3% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, PROCTER & GAMBLE HEALTH has posted a net profit of Rs 441 m (up 34.3% YoY). Sales on the other hand came in at Rs 2 bn (up 6.1% YoY). Read on for a complete analysis of PROCTER & GAMBLE HEALTH's quarterly results.

PROCTER & GAMBLE HEALTH 2017-18 Annual Report Analysis (Annual Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

Here's an analysis of the annual report of PROCTER & GAMBLE HEALTH for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PROCTER & GAMBLE HEALTH. Also includes updates on the valuation of PROCTER & GAMBLE HEALTH.

More Views on News

Most Popular

Multibaggers of the Next Decade(The 5 Minute Wrapup)

Feb 26, 2020

The one key ingredient to be seen amongst top multibaggers of the next decade.

The Next Few Days Are Crucial for Smallcap Investors - And 3 Must-Buy Stocks(Profit Hunter)

Feb 19, 2020

While I have been writing about the rebound in smallcaps for quite some time now... I have shied from the question - When exactly is the smallcap rebound happening. Well, the answer is now.

The Top 8 Trading Mistakes You Should Avoid(Fast Profits Daily)

Feb 18, 2020

Avoid these mistakes and your trading will turn much more profitable.

Corona Virus Could Trigger a Rally in this Stock(Profit Hunter)

Feb 20, 2020

A company which benefits from crude oil and coronavirus - if you would like to know more about it read this.

This is What You Must Know as an Options Trader Today(Fast Profits Daily)

Feb 27, 2020

How you can stay on top of the challenges as an options trader.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get our special report, Secret to Increasing Your Trading Profits Today Now!
We will never sell or rent your email id.
Please read our Terms

PIRAMAL ENTERPRISES SHARE PRICE


Feb 28, 2020 (Close)

TRACK PIRAMAL ENTERPRISES

  • Track your investment in PIRAMAL ENTERPRISES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PIRAMAL ENTERPRISES

PIRAMAL ENTERPRISES - SUN PHARMA COMPARISON

COMPARE PIRAMAL ENTERPRISES WITH

MARKET STATS